Related Experiment Video

Updated: Jun 16, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

Coagulation factor IXa as a target for treatment and prophylaxis of venous thromboembolism

John W Eikelboom1, Steven L Zelenkofske, Christopher P Rusconi

  • 1Regado Biosciences, Inc., 318 Blackwell St, STE 130, Durham, NC 27701, USA.

Arteriosclerosis, Thrombosis, and Vascular Biology
|February 9, 2010
PubMed

Insights

New anticoagulants targeting factor IXa offer potential solutions for venous thromboembolism, addressing limitations in patients with renal impairment and offering full reversal capabilities.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Pharmacology

Background:

  • Venous thromboembolism (VTE) is a significant cause of vascular mortality.
  • Current anticoagulants have limitations, including inadequate options for patients with severe renal impairment and incomplete reversal.
  • Coagulation factor IXa is a key target for novel anticoagulant development due to its role in thrombin generation.

Purpose of the Study:

  • To discuss the rationale for targeting factor IXa in anticoagulant therapy.
  • To review two factor IXa inhibitors, TTP889 and RB006, in early-stage clinical trials for VTE prevention and management.

Main Methods:

  • Review of scientific literature and clinical trial data for factor IXa inhibitors.
  • Discussion of the mechanism of action and therapeutic potential of TTP889 and RB006.
  • Analysis of the role of factor IXa in the coagulation cascade and its implications for VTE.

Main Results:

  • Factor IXa inhibition presents a promising strategy for anticoagulant therapy.
  • TTP889, an oral small-molecule inhibitor, and RB006, an aptamer-based inhibitor, have shown potential in early-phase trials.
  • These agents may address unmet needs in VTE treatment, including in renally impaired patients.

Conclusions:

  • Factor IXa inhibitors represent a novel therapeutic class for venous thromboembolism.
  • TTP889 and RB006 demonstrate potential for VTE prevention and management.
  • Further clinical development is warranted to establish the efficacy and safety of these agents.

More Related Videos

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...